Search

Your search keyword '"Ippazio Cosimo Antonazzo"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Ippazio Cosimo Antonazzo" Remove constraint Author: "Ippazio Cosimo Antonazzo" Search Limiters Full Text Remove constraint Search Limiters: Full Text
44 results on '"Ippazio Cosimo Antonazzo"'

Search Results

1. Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

2. A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

3. Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression

4. Azithromycin use and outcomes in patients with COVID-19: an observational real-world study

5. Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy

6. Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

7. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study

8. Time trends in the incidence of essential tremor: Evidences from UK and France primary care data

9. Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

10. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region

11. Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice

12. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.

13. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders.

14. Abstract P6-08-01: A cost-consequence analysis of pertuzumab in the neoadjuvant treatment of high-risk HER2+ Early-Stage Breast Cancer (EBC): health-economic considerations for drug availability in Italy

15. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up

16. Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study

17. Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women

18. Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

19. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

20. Haemophilia management and treatment: An Italian survey on patients', caregivers' and clinicians' point of view

21. The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis

22. Impact of COVID-19 Lockdown, during the Two Waves, on Drug Use and Emergency Department Access in People with Epilepsy: An Interrupted Time-Series Analysis

23. Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018

24. Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system

25. Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

26. Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study

27. Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

28. Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research

29. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

30. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems

31. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months

32. COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases

33. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

34. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

35. Post-stroke epilepsy and mortality: an observational study on healthcare administrative database

36. 5PSQ-101 Drug–drug interactions and potentially related adverse clinical events in patients with cardiovascular diseases

37. Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting

38. Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

39. Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

40. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres

41. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis

42. Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice

43. PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS

44. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders

Catalog

Books, media, physical & digital resources